1. Construction of homo and heteronuclear Ru (II), Ir (III) and Re (I) complexes for target-specific cancer therapy. 

    Pete, S., Roy, N., Kar, B., Paira, P.

    Coordination chemistry reviews 2022, 460, 214462.

​

​

​

​

​

​

 

2.  Target-specific mononuclear and binuclear rhenium (I) tricarbonyl complexes as upcoming anticancer drugs.

      Sharma, A., Vaibhavi, N., Kar, B., Das, U., Paira, P. 

        RSC Advances 2022, 12(31), 20264-20295.

​

​

​

​

​​​​

3. One-pot three-component synthesis of DNA targeting phototoxic Ru (II)-p-cymene dipyrido [3, 2-a: 2′, 3′-c] phenazine analogues.

    Kar, B., Paira, P.  

    Dalton Transactions 2022, 51(41), 15686-15695.

​

​

​

​

​

​​​

4. In vitro studies on the selective cytotoxic effect of luminescent Ru (II)-p-cymene complexes of imidazo-pyridine and imidazo quinoline ligands. 

    Selvam, P., De, S., Paira, P., Kumar, S. A., Moorthy, A., Ghosh, A., Kuo, Y. C., Banerjee, S., Jenifer, S. K.

    Dalton Transactions 2022, 51(45), 17263-17276.

​

​

​

​

​

​

 

5. Iridium (III)–Cp*-(imidazo [4, 5-f][1, 10] phenanthrolin-2-yl) phenol analogues as hypoxia active, GSH-resistant cancer cytoselective and mitochondria-targeting cancer stem cell therapeutic agents.

    Kar, B., Shanavas, S., Nagendra, A.H., Das, U., Roy, N., Pete, S., Sharma, A., De, S., SK, A.K., Vardhan, S., Sahoo, S.K., Panda, D., Shenoy, S., Bose, B., Paira, P.  

    Dalton Transactions 2022, 51(14), pp.5494-5514.

​

​

​

​

​

​

​

6. Mitochondria-targeted half-sandwich iridium (III)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells MDA-MB-468. 

    Mondal, A., Shanavas, S., Sen, U., Das, U., Roy, N., Bose, B., Paira, P.

    RSC Advances 2022, 12(19), 11953-11966.

​

​

​

​

​

​

 

7. [Ru (η 6-p-cymene)(N^ O 8-hydroxyquinoline)(PTA)] complexes as rising stars in medicinal chemistry: synthesis, properties, biomolecular interactions, in vitro anti-tumor activity toward human brain carcinomas, and in vivo biodistribution and toxicity in a zebrafish model. 

    Anuja, P. K., Roy, N., Das, U., Varddhan, S., Sahoo, S. K., Paira, P.

    Dalton Transactions 2022, 51(21), 8497-8509.

​

​

​

​

​

​

​

8. Ru (II) arene (N^N bpy/phen)-based RAPTA complexes for in vitro anti-tumour activity in human glioblastoma cancer cell lines and in vivo toxicity studies in a zebrafish model.

    Anuja, P. K., Kar, B., Roy, N., Paira, P.  

    RSC advances 2022, 12(29), 18911-18922.

​

​

​

​

​

​

​

​

​

​